Japanese Government Procurement
National University Corporation - Notice of Procurement (Goods & Services)A AndexanetAlfa(200mg/1vail)67vials,B Efgartigimod Alfa (Genetical Recombination) (400mg20ml/1vial) 48 vials
This procurement is covered by the WTO Agreement on Government Procurement, Japan-EU Economic Partnership Agreement or Japan-UK Comprehensive Economic Partnership Agreement.
| Publishing date | May 08, 2023 |
|---|---|
| Type of notice | Notice of Procurement (Goods & Services) |
| Procurement entity | National University Corporation - Toyama |
| Classification |
0004 Medical & Pharmaceutical Products |
| Summay of notice | ⑴ Official in charge of disbursement of the procuring entity : Hiroshi Mizoguchi, The Obligating Officer for Contractual Affairs Delegate Head, Finance and Facilities Department University of Toyama ⑵ Classification of the products to be procured : 4 ⑶ Nature and quantity of the products to be purchased : A AndexanetAlfa(200mg/1vail)67vials B Efgartigimod Alfa (Genetical Recombination) (400mg20ml/1vial) 48 vials ⑷ Delivery period : From 1 July, 2023 through 30 June, 2024 ⑸ Delivery place : The places specified by the Obligating Officer for Contractual Affairs Delegate Head ⑹ Qualifications for participating in the tendering procedures : Suppliers eligible for participating in the proposed tender are those who shall : A not come under Article 5 and 6 of the Regulation concerning the Contract for University of Toyama Furthermore, minors, Person under Conservatorship or Person under Assistance that obtained the consent necessary for concluding a contract may be applicable under cases of special reasons within the said clause, B have the Grade A, Grade B or Grade C qualification during fiscal 2023 in the Tokai・Hokuriku area in sales of product for participating in tenders by Single qualification for every ministry and agency, C prove to have obtained the first-class license for selling drugs in accordance with the Law on Securing Quality, Efficacy and Safety of Products including Pharmaceuticals and Medical Devices, D meet the qualification requirements which The Obligating Officer Director-General may specify in accordance with Article 8 of the Regulation, E not be currently under a suspension of business order as instructed by The Obligating Officer Director-General. ⑺ Time limit of tender : A 10 : 00 30 June, 2023 B 10 : 20 30 June, 2023 ⑻ Contact point for the notice : Shiori Hamada, Accounting Division II Finance and Facilities Department University of Toyama, 2630 Sugitani Toyama-shi 930-0194 Japan, TEL 076-434-7050 ⑼ Please be noted that if it is indicated that environmental conditions relating to the procurement are laid down in its tender documents. |


